Five-Year Overall Survival Analysis Using First- and Second-Generation Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia in the Chronic Phase in a Prospective Observational Study (SIMPLICITY)

Five-Year Overall Survival Analysis Using First- and Second-Generation Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia in the Chronic Phase in a Prospective Observational Study (SIMPLICITY)

Saved in:
Bibliographic Details
Published in:Blood Vol. 140; no. Supplement 1; pp. 9624 - 9625
Main Authors: Mauro, Michael, Paquette, Ronald, Hehlmann, Rüdiger, Williams, Loretta A., Goldberg, Stuart L., Michallet, Mauricette, Gambacorti-Passerini, Carlo, Tang, Derek, DeGutis, Irene S., McBride, Ali, Parsons, Lori, Montelongo, Monica Z., Cortes, Jorge E.
Format: Journal Article
Language:English
Published: Elsevier Inc 15-11-2022
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0006-4971
1528-0020
DOI:10.1182/blood-2022-163080